A 4-week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect on Metabolic Parameters in a Randomized Trial
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (10) , 2267-2274
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesityNutrition & Diabetes, 2013
- A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult menBrain Research, 2012
- Framework for sex differences in adolescent neurobiology: A focus on cannabinoidsNeuroscience & Biobehavioral Reviews, 2011
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in miceJournal of Clinical Investigation, 2008
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled studyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo‐controlled studyNeurogastroenterology & Motility, 2006
- Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the ratPhysiology & Behavior, 2004
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexusJournal of Comparative Neurology, 2002